Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide.

Taraborelli M, Monari P, Cavazzana I, Gualdi G, Calzavara-Pinton P, Franceschini F.

Joint Bone Spine. 2015 Mar;82(2):130-1. doi: 10.1016/j.jbspin.2014.05.005. Epub 2014 Jun 27. No abstract available.

PMID:
24986684
2.

Type 1 cryoglobulinemia: response to thalidomide and lenalidomide.

Calabrese C, Faiman B, Martin D, Reu F, Calabrese LH.

J Clin Rheumatol. 2011 Apr;17(3):145-7. doi: 10.1097/RHU.0b013e3182155e8d. No abstract available.

PMID:
21441816
3.

Mixed-cryoglobulinemia associated with cutaneous vasculitis and pulmonary symptoms.

Konishi M, Ohosone Y, Matsumura M, Oyamada Y, Yamaguchi K, Kawahara Y, Mimori T, Ikeda Y.

Intern Med. 1997 Jan;36(1):62-7.

4.

Combination therapy of prednisolone and mizoribine improves cryoglobulinemic vasculitis with purpura and skin ulcers.

Hamaguchi M, Kawahito Y, Tsubouchi Y, Kohno M, Yamamoto A, Ishino H, Wada M, Yoshikawa T.

Clin Rheumatol. 2007 Jul;26(7):1170-2. Epub 2006 Apr 14.

PMID:
16614792
6.

[Type I cryoglobulinemia with a fatal outcome].

Echeverría B, Vitiello M, Abuchar A, Kerdel FA.

Actas Dermosifiliogr. 2011 Apr;102(3):212-5. doi: 10.1016/j.ad.2010.10.011. Epub 2011 Mar 3. Spanish.

PMID:
21376295
7.

Cutaneous sarcoidosis successfully treated with low doses of thalidomide.

Rousseau L, Beylot-Barry M, Doutre MS, Beylot C.

Arch Dermatol. 1998 Aug;134(8):1045-6. No abstract available.

PMID:
9722748
8.

Long-term plasmapheresis in conjunction with thalidomide and dexamethasone for the treatment of cutaneous ulcers and neovascular glaucoma in recalcitrant type I cryoglobulinemia.

Yang CH, Qureshi AA, Churchill WH, Saavedra AP.

JAMA Dermatol. 2014 Apr;150(4):426-8. doi: 10.1001/jamadermatol.2013.8700.

PMID:
24553496
10.

[Renaissance of thalidomide].

Waelput F, Feremans W, Heenen M, Sternon J.

Rev Med Brux. 2002 Dec;23(6):504-11. Review. French.

PMID:
12584947
11.

Severe cutaneous ulceration following treatment with thalidomide for GVHD.

Schlossberg H, Klumpp T, Sabol P, Herman J, Mangan K.

Bone Marrow Transplant. 2001 Jan;27(2):229-30.

12.

Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide.

Nair V, Sharma A, Ghosh I, Arora S, Sahai K, Dutta V.

J Assoc Physicians India. 2005 Nov;53:988-90.

PMID:
16515241
13.

Essential type II mixed cryoglobulinemia causing pyoderma gangrenosum-like ulcers.

Namazi MR, Kerchner KR, Pichardo RO.

ScientificWorldJournal. 2008 Feb 25;8:228. doi: 10.1100/tsw.2008.44.

14.

Dramatic improvement of primary cutaneous amyloidosis with thalidomide.

An Q, Lin J, Zheng S, Hong Y, Zhang L, Guan X, Xu XG, Chen HD, Gao XH.

Eur J Dermatol. 2011 Mar-Apr;21(2):270-1. doi: 10.1684/ejd.2010.1228. No abstract available.

PMID:
21382777
15.

IgG4-related skin disease successfully treated by thalidomide: a report of 2 cases with emphasis on pathological aspects.

Ingen-Housz-Oro S, Ortonne N, Elhai M, Allanore Y, Aucouturier P, Chosidow O.

JAMA Dermatol. 2013 Jun;149(6):742-7. doi: 10.1001/jamadermatol.2013.2625.

PMID:
23572226
16.

Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.

Lin RJ, Curran JJ, Zimmerman TM, Song J, Niewold TB, Sweiss NJ.

J Clin Rheumatol. 2010 Mar;16(2):90-1. doi: 10.1097/RHU.0b013e3181d0bfef. No abstract available.

17.

IgG4-related skin disease.

Lehman JS, Pittelkow MR, Smyrk TC.

JAMA Dermatol. 2013 Dec;149(12):1439-40. doi: 10.1001/jamadermatol.2013.7326. No abstract available.

PMID:
24352725
18.

Thalidomide in dermatology. New indications for an old drug.

Calderon P, Anzilotti M, Phelps R.

Int J Dermatol. 1997 Dec;36(12):881-7. Review. No abstract available.

PMID:
9466191
19.

Flare of essential mixed cryoglobulinemic vasculitis with hemorrhagic bullous purpura after rituximab infusion.

Zenone T.

Int J Rheum Dis. 2013 Apr;16(2):237-9. doi: 10.1111/1756-185X.12114. No abstract available.

PMID:
23773652
20.

IgG4-related skin disease--reply.

Ingen-Housz-Oro S, Ortonne N, Chosidow O.

JAMA Dermatol. 2013 Dec;149(12):1440. doi: 10.1001/jamadermatol.2013.7329. No abstract available.

PMID:
24352726

Supplemental Content

Support Center